Evidence map›Paper›PMID 26646781›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2016

Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.

Carina Stegmayr, Michael Schöneck, Dennis Oliveira, Antje Willuweit, Christian Filss, Norbert Galldiks, N Jon Shah, Heinz H Coenen, Karl-Josef Langen

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. High uptake ofEJNMMI research · 2020
    Article
  5. Influence of Dexamethasone on O-(2-[Molecular imaging and biology · 2019
    Article
  6. The British journal of radiology · 2018
    Article
  7. Evaluation of factors influencingNeuroImage. Clinical · 2018
    Article
  8. Influence of blood-brain barrier permeability on O-(2-European journal of nuclear medicine and molecular imaging · 2017
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Carina StegmayrResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
Michael SchöneckResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
Dennis OliveiraResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
Antje WilluweitResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
Christian FilssResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
Norbert GalldiksResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
N Jon ShahResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
Heinz H CoenenResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany.
Karl-Josef LangenResearch Center Jülich, Institute of Neuroscience and Medicine, Jülich, Germany. k.j.langen@fz-juelich.de.
Forschungszentrum Jülich · DERWTH Aachen University · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePositron emission tomography (PET) using O-(2-(18)F-fluoroethyl)-L-tyrosine ((18)F-FET) is a well-established method for the diagnostics of brain tumors. This study investigates reproducibility of (18)F-FET uptake kinetics in rat gliomas and the influence of the frequently used dexamethasone (Dex) therapy.

methodsF98 glioma or 9L gliosarcoma cells were implanted into the striatum of 31 Fischer rats. After 10-11 days of tumor growth, the animals underwent dynamic PET after injection of (18)F-FET (baseline). Thereafter, animals were divided into a control group and a group receiving Dex injections, and all animals were reinvestigated 2 days later. Tumor-to-brain ratios (TBR) of (18)F-FET uptake (18-61 min p.i.) and the slope of the time-activity-curves (TAC) (18-61 min p.i.) were evaluated using a Volume-of-Interest (VOI) analysis. Data were analyzed by two-way repeated measures ANOVA and reproducibility by the intraclass correlation coefficient (ICC).

resultsThe slope of the tumor TACs showed high reproducibility with an ICC of 0.93. A systematic increase of the TBR in the repeated scans was noted (3.7 ± 2.8 %; p < 0.01), and appeared to be related to tumor growth as indicated by a significant correlation of TBR and tumor volume (r = 0.77; p < 0.0001). After correction for tumor growth TBR showed high longitudinal stability with an ICC of 0.84. Dex treatment induced a significant decrease of the TBR (-8.2 ± 6.1 %; p < 0.03), but did not influence the slope of the tumor TAC.

conclusionTBR of (18)F-FET uptake and tracer kinetics in brain tumors showed high longitudinal stability. Dex therapy may induce a minor decrease of the TBR; this needs further investigation.

Indexed as

AnimalsBiological TransportBrain NeoplasmsDexamethasoneDisease Models, AnimalGliomaKineticsMalePositron-Emission TomographyRatsReproducibility of ResultsTyrosineDexamethasoneO-(2-fluoroethyl)tyrosineTyrosineBrain tumorsDexamethasone treatmentO-(2-[18F]fluoroethyl)-L-tyrosine (FET)PETRat glioma modelReproducibility

Identifiers

PMID26646781
OpenAlexW2194986034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.